发明名称 INHIBITION OF PCSK9 THROUGH RNAI
摘要 The invention relates to various PCSK9 RNAi constructs with gene silencing activities, and uses thereof The construct has a double- stranded region of 19-49 nucleotides, preferably 25, 26, or 27 nucleotides, and preferably blunt-ended The construct has selective minimal modifications to confer an optimal balance of biological activity, toxicity, stability, and target gene specificity The sense strand may be modified such that the construct is not cleaved by Dicer or other RNAse III, and the entire length of the antisense strand is loaded into RISC In addition, the antisense strand may also be modified by 2'-O-methyl groups at the 2nd 5'-end nucleotide to greatly reduce off-target silencing The constructs of the invention largely avoid the interferon response and sequence-independent apoptosis in mammalian cells, exhibits better serum stability, and enhanced target specificity.
申请公布号 WO2010078536(A1) 申请公布日期 2010.07.08
申请号 WO2010US00019 申请日期 2010.01.05
申请人 RXI PHARMACEUTICALS CORPORATION;KAMENS, JOANNE;KHVOROVA, ANASTASIA 发明人 KAMENS, JOANNE;KHVOROVA, ANASTASIA
分类号 A61K31/7115;A61K31/712;A61K31/7125 主分类号 A61K31/7115
代理机构 代理人
主权项
地址